Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V<sub>H</sub>H Domain

Interleukin-17 (IL-17) is a cytokine produced by the Th17 cells. It is involved in chronic inflammation in patients with autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and psoriasis. The antibodies targeting IL-17 and/or IL-17R are therapy tools...

Full description

Bibliographic Details
Main Authors: Olga Kostareva, Arina Svoeglazova, Ilya Kolyadenko, Alexey Nikulin, Stanislav Evdokimov, Uliana Dzhus, Azat Gabdulkhakov, Svetlana Tishchenko
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/23/14904
_version_ 1797463102391844864
author Olga Kostareva
Arina Svoeglazova
Ilya Kolyadenko
Alexey Nikulin
Stanislav Evdokimov
Uliana Dzhus
Azat Gabdulkhakov
Svetlana Tishchenko
author_facet Olga Kostareva
Arina Svoeglazova
Ilya Kolyadenko
Alexey Nikulin
Stanislav Evdokimov
Uliana Dzhus
Azat Gabdulkhakov
Svetlana Tishchenko
author_sort Olga Kostareva
collection DOAJ
description Interleukin-17 (IL-17) is a cytokine produced by the Th17 cells. It is involved in chronic inflammation in patients with autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and psoriasis. The antibodies targeting IL-17 and/or IL-17R are therapy tools for these diseases. Netakimab is an IL-17A-specific antibody containing a <i>Lama glama</i> V<sub>H</sub>H derivative domain and a VL variable domain. We have determined the crystal structure of the IL-17A-specific V<sub>H</sub>H domain in complex with IL-17A at 2.85 Å resolution. Certain amino acid residues of the three complementary-determining regions of the V<sub>H</sub>H domain form a network of solvent-inaccessible hydrogen bonds with two epitope regions of IL-17A. The β-turn of IL-17A, which forms the so-called epitope-1, appears to be the main region of IL-17A interaction with the antibody. Contacts formed by the IL-17A mobile C-terminal region residues (epitope-2) further stabilize the antibody–antigen complex.
first_indexed 2024-03-09T17:45:53Z
format Article
id doaj.art-d2724b90e44c4ed495bbc5e7d6236209
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T17:45:53Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d2724b90e44c4ed495bbc5e7d62362092023-11-24T11:09:54ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-11-0123231490410.3390/ijms232314904Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V<sub>H</sub>H DomainOlga Kostareva0Arina Svoeglazova1Ilya Kolyadenko2Alexey Nikulin3Stanislav Evdokimov4Uliana Dzhus5Azat Gabdulkhakov6Svetlana Tishchenko7Institute of Protein Research, Russian Academy of Sciences, Institutskaya, 4, 142290 Pushchino, RussiaInstitute of Protein Research, Russian Academy of Sciences, Institutskaya, 4, 142290 Pushchino, RussiaInstitute of Protein Research, Russian Academy of Sciences, Institutskaya, 4, 142290 Pushchino, RussiaInstitute of Protein Research, Russian Academy of Sciences, Institutskaya, 4, 142290 Pushchino, RussiaCJSC Biocad, ul.Svyazi., 34-A, sett. Strelna, 198515 Saint-Petersburg, RussiaInstitute of Protein Research, Russian Academy of Sciences, Institutskaya, 4, 142290 Pushchino, RussiaInstitute of Protein Research, Russian Academy of Sciences, Institutskaya, 4, 142290 Pushchino, RussiaInstitute of Protein Research, Russian Academy of Sciences, Institutskaya, 4, 142290 Pushchino, RussiaInterleukin-17 (IL-17) is a cytokine produced by the Th17 cells. It is involved in chronic inflammation in patients with autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and psoriasis. The antibodies targeting IL-17 and/or IL-17R are therapy tools for these diseases. Netakimab is an IL-17A-specific antibody containing a <i>Lama glama</i> V<sub>H</sub>H derivative domain and a VL variable domain. We have determined the crystal structure of the IL-17A-specific V<sub>H</sub>H domain in complex with IL-17A at 2.85 Å resolution. Certain amino acid residues of the three complementary-determining regions of the V<sub>H</sub>H domain form a network of solvent-inaccessible hydrogen bonds with two epitope regions of IL-17A. The β-turn of IL-17A, which forms the so-called epitope-1, appears to be the main region of IL-17A interaction with the antibody. Contacts formed by the IL-17A mobile C-terminal region residues (epitope-2) further stabilize the antibody–antigen complex.https://www.mdpi.com/1422-0067/23/23/14904interleukin 17A in complex with V<sub>H</sub>H domainnetakimabcrystal structure
spellingShingle Olga Kostareva
Arina Svoeglazova
Ilya Kolyadenko
Alexey Nikulin
Stanislav Evdokimov
Uliana Dzhus
Azat Gabdulkhakov
Svetlana Tishchenko
Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V<sub>H</sub>H Domain
International Journal of Molecular Sciences
interleukin 17A in complex with V<sub>H</sub>H domain
netakimab
crystal structure
title Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V<sub>H</sub>H Domain
title_full Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V<sub>H</sub>H Domain
title_fullStr Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V<sub>H</sub>H Domain
title_full_unstemmed Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V<sub>H</sub>H Domain
title_short Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V<sub>H</sub>H Domain
title_sort two epitope regions revealed in the complex of il 17a and anti il 17a v sub h sub h domain
topic interleukin 17A in complex with V<sub>H</sub>H domain
netakimab
crystal structure
url https://www.mdpi.com/1422-0067/23/23/14904
work_keys_str_mv AT olgakostareva twoepitoperegionsrevealedinthecomplexofil17aandantiil17avsubhsubhdomain
AT arinasvoeglazova twoepitoperegionsrevealedinthecomplexofil17aandantiil17avsubhsubhdomain
AT ilyakolyadenko twoepitoperegionsrevealedinthecomplexofil17aandantiil17avsubhsubhdomain
AT alexeynikulin twoepitoperegionsrevealedinthecomplexofil17aandantiil17avsubhsubhdomain
AT stanislavevdokimov twoepitoperegionsrevealedinthecomplexofil17aandantiil17avsubhsubhdomain
AT ulianadzhus twoepitoperegionsrevealedinthecomplexofil17aandantiil17avsubhsubhdomain
AT azatgabdulkhakov twoepitoperegionsrevealedinthecomplexofil17aandantiil17avsubhsubhdomain
AT svetlanatishchenko twoepitoperegionsrevealedinthecomplexofil17aandantiil17avsubhsubhdomain